Atai stock forecast.

Based on 3 Wall Street analysts offering 12 month price targets for SomaLogic in the last 3 months. The average price target is $2.40 with a high forecast of $2.50 and a low forecast of $2.30. The average price target represents a -2.04% change from the last price of $2.45. Highest Price Target $2.50. Average Price Target $2.40.Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.ATAI stock is down 44% year-to-date (YTD), despite a 10% increase over the past month. Shares are changing hands at 2.4x book value. Wall Street’s 12-month median price forecast for ATAI stock ...The average Bionano Genomics stock price prediction forecasts a potential upside of 532.91% from the current BNGO share price of $1.58. What is BNGO's forecast return on assets (ROA) for 2023-2026? (NASDAQ: BNGO) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 0.13%.The social networking company earned $1.28 billion during the quarter, compared to analyst estimates of $1.28 billion. Twitter had a negative net margin of 2.14% and a negative trailing twelve-month return on equity of 0.82%. The firm's revenue was up 37.1% compared to the same quarter last year.

Nov 17, 2023 · According to the issued ratings of 1 analysts in the last year, the consensus rating for Arcadia Biosciences stock is Buy based on the current 1 buy rating for RKDA. The average twelve-month price prediction for Arcadia Biosciences is $15.00 with a high price target of $20.00 and a low price target of $10.00. Learn more on RKDA's analyst rating ...

EOSE Stock 12 Months Forecast. $10.50. (845.95% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Eos Energy Enterprises in the last 3 months. The average price target is $10.50 with a high forecast of $17.00 and a low forecast of $2.00. The average price target represents a 845.95% change from the last price of $1.11.Market caps as of Oct. 23, 2023. Company. Market Cap. Description. Atai Life Sciences ( NASDAQ:ATAI ) $215.8 million. Developing multiple drugs based on psychedelic substances, including ibogaine ...

Stock analysis for ATAI Life Sciences NV (ATAI:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.ATAI Life Sciences NV. $1.12. ATAI 7.69% ; Enveric Biosciences Inc. $1.68. ENVB 13.51% ; Compass Pathways PLC. $6.10. CMPS 2.01% ; ehave Inc. $0.0017. EHVVF 0.00%.The current price was close to the IPO price in September 2020. The $21.81 stock price right now is eight percent lower than the original $23.4 price. There is still hope for recovery if the price does not plunge toward zero. The technical outlook of this stock is pretty much the same as that of Atai. Mind Medicine (MNMD)Atai Life Sciences Announces Results from the Phase 1 Iv-To-Subcutaneous Bridging Study of Pcn-101 (R-Ketamine) Aug. 08: CI Atai Life Sciences N.V., Atai Life Sciences AG Enters into the Second Amendment to Loan and Security Agreement with the Several Banks May. 31: CI20. 11. 2023. ... The company's 5Y monthly beta was ticking 0.83. Taking into account the 52-week price action we note that the stock hit a 52-week high of $3.65 ...

ATAI Stock 12 Months Forecast. $14.00. (960.61% Upside) Based on 4 Wall Street analysts offering 12 month price targets for ATAI Life Sciences in the last 3 months. The average price target is $14.00 with a high forecast of $20.00 and a low forecast of $11.00. The average price target represents a 960.61% change from the last price of $1.32.

NEW YORK and BERLIN, Sept. 14, 2023 (GLOBE NEWSWIRE) -- atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 Cantor Fitzgerald Global Healthcare Conference. September 14, 2023. Press Release.

Sep 9, 2022 · Presently, ATAI is trading below its 20W EMA, which is an extremely serious red flag. In fact, ATAI only closed above its 20W EMA once, back in late 2021. It’s just that simple to determine if the stock is or was ever a buy. Quick answer – NO! In 2020 and 2021, ATAI spent almost $60M total on R&D. Dec 1, 2023 · The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ... 4 brokers have issued 1-year price targets for Atai Life Sciences' stock. Their ATAI share price targets range from $9.00 to $20.00. On average, they expect the …WebHistorical and current end-of-day data provided by . All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday ... Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.

Oct 2, 2023 · 3:24 pm. Articles. atai Life Sciences Reports Second Quarter 2023 Financial Results and Operational Highlights, and Announces Clinical Data from the Phase 1 Study of DMX-1002 (Ibogaine) August 10, 2023 Advanced multiple clinical stage assets in development, including the on-going Phase 2b study of RL-007 in patients…. August 10, 2023. TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comatai Life Sciences N.V. - Buy. Zacks' proprietary data indicates that atai Life Sciences N.V. is currently rated as a Zacks Rank 2 and we are expecting an above average return from the ATAI shares ...CLLS Stock 12 Months Forecast. $6.33. (116.04% Upside) Based on 4 Wall Street analysts offering 12 month price targets for Cellectis SA in the last 3 months. The average price target is $6.33 with a high forecast of $10.00 and a low forecast of $3.00. The average price target represents a 116.04% change from the last price of $2.93. 28.98. According to our current ATAI stock forecast, the value of Atai Life Sciences N.V. shares will drop by -18.90% and reach $ 0.875911 per share by December 3, 2023. …WebFind real-time SMCI - Super Micro Computer Inc stock quotes, company profile, news and forecasts from CNN Business.

Find real-time DTIL - Precision BioSciences Inc stock quotes, company profile, news and forecasts from CNN Business.3. 4. 2023. ... As atai currently has a stock price of $1.83 and a market cap of $304 million. Meaning it is trading at a 14% discount. And again, that ...

Nov 28, 2023 · ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with ... ATAI Life Sciences NV Stock Forecast. Is ATAI Life Sciences NV Stock Undervalued? The current ATAI Life Sciences NV [ ATAI] share price is $1.06. The Score for ATAI is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. ATAI is currently trading in the 10-20% percentile range relative to its historical ... NL0015000DX5. ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. It engages in the treatment of mental health disorders. The company was founded by Christian Angermayer, Florian Brand, Srinivas Rao and Lars Christian Wilde in June 2018 and is headquartered in Berlin, Germany. Show more.30. 8. 2022. ... Wall Street's 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS). magic mushrooms representing champion ...Meanwhile, Atai listed on the Nasdaq in June, raising $225 million at a valuation of $2.3 billion. The stock immediately popped 40% but it has since halved in value and Atai's current market cap ...Find real-time TLRY - Tilray Brands Inc stock quotes, company profile, news and forecasts from CNN Business.AI is a growth business. Total spending on AI systems is forecast to reach $97.9 billion in 2023, up from $37.5 billion in 2019. For the five-year period ending in 2023, the AI sector is predicted ...

Even in a speculative industry, I believe the stock is undervalued by these few facts alone. ATAI holds: 450M cash and cash equivalents; 20% equity stake in CMPS (750M mktcp - 150M worth at current prices); and ATAI has a vast ip pipeline that includes 9 lead compounds. Curious as to the community’s thoughts here!

Market cap is calculated by taking a company's price per share and multiplying it by the company's total number of shares outstanding. $214.15M. -60.0%. Market Cap / Employee. The market cap of a ...

VRNOF Stock 12 Months Forecast. $8.01. (88.03% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Verano Holdings in the last 3 months. The average price target is $8.01 with a high forecast of $10.00 and a low forecast of $6.00. The average price target represents a 88.03% change from the last price of $4.26.Stock Price Forecast The 6 analysts offering 12-month price forecasts for Ouster Inc have a median target of 9.50, with a high estimate of 12.00 and a low estimate of 6.00.Their CMPS share price targets range from $19.00 to $120.00. On average, they anticipate the company's stock price to reach $46.83 in the next year. This suggests a possible upside of 683.2% from the stock's current price. View analysts price targets for CMPS or view top-rated stocks among Wall Street analysts.Dec 15, 2022 · What's Happening With ATAI Life Sciences NV Stock Today? ATAI Life Sciences NV (ATAI) stock is trading at $3.05 as of 3:20 PM on Thursday, Dec 15, a drop of -$0.05, or -1.77% from the previous closing price of $3.10. The stock has traded between $2.98 and $3.10 so far today. Volume today is low. From July 11 to July 13, Wood purchased 947,340 shares of BFLY stock. 5. ATAI Life Sciences (ATAI) ... Stocks to Buy AMZN Stock Forecast: Predicting Amazon’s Performance in 2023 and BeyondRPHM. Reneo Pharmaceuticals Inc. 6.04. +0.10. +1.68%. Get ATAI Life Sciences NV (ATAI:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Read an investment analysis of ATAI stock here. ... By 2029, it is forecast to be worth $7.2 billion globally, with a compound annual growth rate of 55%. Also, ...WebThe stock ranks in the lowest position of the 53 stocks owned by the ETF. Atai was the third psychedelics company to go public with an IPO in June 2021, following Mind Medicine Inc MNMD and ...

Get ATAI Life Sciences NV (ATAI.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments.Find real-time ATAI - ATAI Life Sciences NV stock quotes, company profile, news and forecasts from CNN Business.WebAll 39 ARKG ETF Holdings. The portfolio of Cathie Wood updated daily. These are the positions, trades, and weight of all companies in her ARKG Genomic Revolution ETF. Search tickers or categories... Trader's Guide 2024 Ships December 21st.Shares of the Peter Thiel -backed psychedelic start-up Atai Life Sciences jumped Friday on their first day of trading on Wall Street. The newly listed Nasdaq stock opened up 40% before pulling ...Instagram:https://instagram. best dental insurance new yorktop ten health insurance companies in texasmortgage lenders for small business ownersbest month to buy stocks Find the latest Sorrento Therapeutics, Inc. (SRNEQ) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term ...Dec 1, 2023 · The ATA Inc. stock price gained 7.69% on the last trading day (Friday, 1st Dec 2023), rising from $1.04 to $1.12. During the last trading day the stock fluctuated 12.20% from a day low at $1.03 to a day high of $1.15. The price has risen in 5 of the last 10 days and is up by 0.9% over the past 2 weeks. Volume fell on the last day by -2 million ... forex brokers canadaiqlt 3 Wall Street research analysts have issued twelve-month target prices for Trulieve Cannabis' stock. Their TCNNF share price targets range from $6.00 to $132.00. On average, they anticipate the company's stock price to reach $42.92 in the next year. This suggests a possible upside of 693.3% from the stock's current price.The total addressable market for AI is massive; by 2030, it's expected to be worth nearly $2 trillion, according to Statista. That's a massive pie, and multiple companies will be vying for these ... caterpillar stock dividend Atai's stock is hurting, but its pipeline is still packed with promising programs. With its shares down by 60% in the last 12 months and a recent layoff …WebFind real-time NEE - Nextera Energy Inc stock quotes, company profile, news and forecasts from CNN Business.